GAINESVILLE, Ga., June 11, 2020 (GLOBE NEWSWIRE) -- Recro Gainesville, Inc. (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions for the ...

MALVERN, Pa., March 04, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospitals and other acute care ...

Business Poised to Continue Driving Revenue and Begin Generating Profits Recro Will Continue to Trade on NASDAQ Under Ticker Symbol “REPH” MALVERN, Pa., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, ...

With manufacturing operations already locked up in Georgia, Recro Pharma is taking its CDMO ambitions coast-to-coast. Recro has dished out nearly $50 million to acquire CDMO peer Irisys. The deal for ...

GAINESVILLE, Ga.--(BUSINESS WIRE)--Recro Gainesville, LLC, a wholly owned subsidiary of Recro Pharma, Inc., and a leading provider of solid oral dose manufacturing services for the pharmaceutical ...

EXTON, Pa., May 12, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD:REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and ...

GAINESVILLE, Ga., April 15, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. ("Recro"; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and ...

RADNOR, Pa.--(BUSINESS WIRE)--Kaskela Law LLC has filed a shareholder class action lawsuit against Recro Pharma, Inc. (NASDAQ: REPH) (“Recro” or the “Company”) on behalf of investors who purchased or ...

SAN DIEGO and GAINESVILLE, Ga., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. ("Recro"; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple ...